Wikidata

(Q63576351)

English

A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis

clinical trial

In more languages

Statements

title
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis (English)
0 references
country
Argentina
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Romania
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
9 May 2017
0 references
end time
22 May 2020
0 references
number of participants
750
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63576351&oldid=1857269428"